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ABSTRACT
Aims: Retained placenta (RP) is a major cause of 
obstetric haemorrhage. The aim of the study was to 
obtain a better understanding of the mechanisms that 
cause some placentas to become retained, while most 
are not.
Methods: 23 RPs clinically diagnosed as placenta 
adhesiva and 10 control placentas (CPs) were examined 
for differences in trophoblast fusion into multinucleated 
trophoblastic giant cells (MTGCs), defects in the basal 
decidua, and decidual attachment of myometrial fibres. 
Results: The number of MTGCs in the basal decidua was 
significantly smaller in RPs (0.23 MTGC/standard length) 
than in CPs (1.11 MTGC/standard length) (p<0.001). 
Defects in the decidua were observed in 4% of the RPs 
and in 0% of the CPs. Myometrial fibres were attached to 
the decidua in 78% of the RPs and in 0% of the CPs 
(p<0.001).
Conclusions: In placenta adhesiva compared with CPs, 
significantly less MTGCs were present in the basal 
decidua, the basal decidua was intact, and myometrial 
fibres were more frequently attached to the basal 
decidua. It is speculated that these findings may indicate 
that defective fusion of trophoblastic cells into MTGCs 
plays a causative role in placenta adhesiva.
Retained placenta (RP) is a major cause of 
postpartum  haemorrhage1 and m aternal mortality 
worldwide.2 Several degrees of adherence of the 
placenta to the uterine wall can be identified: 
placenta adhesiva, accreta, increta and percreta The 
m ost common type of RP associated w ith  abnor­
mal placental adherence is placenta adhesiva (PA), 
w ith  an incidence of 1.8% in nulliparous w om en.1 
PA is an abnormal adherence of the placenta to the 
uterine wall, w ith  a clear separation plane found 
during manual removal of the placenta.3 The 
mechanisms underlying abnormal placental adhe­
sion in PA are not well understood.
Placenta accreta happens far more infrequently 
(in ü.014-0.3%4-6) than PA and has tw o definitions. 
The clinical definition of placenta accreta is tha t of 
an absent clear separation plane during manual 
removal, resulting in a difficult manual removal in 
pieces.4 7 The histological definition of placenta 
accreta is tha t of defects in the basal decidua and 
myometrial fibres attached to the basal decidua.7 8 
Placenta accreta, as dem onstrated by (partial) 
absence of basal decidua,7-9 is associated w ith  
damage caused by prior uterine surgery, including 
caesarean section and curettage, placenta praevia
and advanced m aternal age.5 6 Such associations are 
not clear for PA.10-12
Inhibition of trophoblast invasion is essential for 
normal adhesion and expulsion of the human 
placenta after delivery of the infant. The apoptotic 
rate of invasive trophoblastic cells in term placentas 
is close to zero.13 Frank and Kaufmann postulated 
that the main mechanism by which trophoblast cells 
lose their initial invasive character is syncytial fusion 
that results in their incorporation into m ultinu­
cleated trophoblastic giant cells (MTGCs).14-16 This 
concept was supported by the observation of relative 
absence of MTGCs in hum an postpartum hyster­
ectomy specimens of placenta increta and percreta,9 
whereas normal placentas contain MTGCs in the 
basal decidua in 100% and in the myometrium in 
more than 50% of cases.13
The possible causes of PA, the most common 
form of RP, have not been studied in any detail. 
Analogous to the causes of placenta accreta, one 
might argue that relative absence of syncytial 
fusion or absence of basal decidua could play a 
causative role. Therefore, the aim of this study was 
to get a better understanding of the mechanisms 
underlying PA by determining the association of 
PA w ith  (1) the num ber of MTGCs, (2) the 
presence of defects of the basal deciduas, and (3) 
the presence of attachm ent of myometrial fibres to 
the basal decidua, as a sign of abnormal adherence.
MATERIALS AND METHODS 
Study group and controls
Tw enty-three placentas clinically diagnosed as PA 
and 10 control placentas (CPs) were included in 
this study. The obstetric history of the study 
patients is shown in table 1. All wom en had an 
uncomplicated pregnancy and a gestational age of 
at least 37 weeks.
RP was defined as a placenta that had not been 
expelled at 60 min after the delivery of the infant, 
despite active management of the third stage w ith 
oxytocin, controlled cord traction and catheterisation 
of the urinary bladder.17 PA was defined as a RP that, 
during manual removal, was adherent to the uterine 
wall w ithout clinical signs of placenta accreta (ie, 
difficult removal of placenta in pieces). The CPs were 
expelled w ithin 10 min after delivery of the infant. 
All patients gave their informed consent.
Histology
The placentas were preserved in 4% buffered 
formalin. From each RP, four sections were taken.
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Table 1 Obstetric history of patients with retained and control 
placentas
Control
p lace n tas
Retained
p lace n tas p V alue
No. of patients 10 23
Nullipara 4 12 NS
Multipara 6 11 NS
Gestational age, 
w eeks*
40.6 (37.9-43.2) 40.3 (37.3-42.3) NS
Previous retained 
placenta, n (%)
0 (0 ) 5 (45{) < 0 .0 5
Previous caesarean, n 
(%)
0 (0) 2 (18{) NS
Previous curettage, n 
(%)
1 (10) 3 (13{) NS
*M edian (range); {Percentage in multiparous wom en; {Percentage in all women. 
NS, not significant.
Two sections were taken from the macroscopically damaged 
basal plate, because it has been shown previously that the 
junction between the intact and disrupted basal plate is the 
optimal sampling location for the detection of myometrial 
fibres.18 In addition, two random full-thickness sections were 
taken, containing decidua basalis from the peripheral and 
central parenchyma. All CPs were macroscopically intact, and 
four random full thickness sections were taken from each.
The tissue samples were routinely processed and stained with 
haematoxylin and eosin. Two experienced observers (HvB and 
JB), blinded to the clinical data, examined the slides together 
and scored them in consensus. All slides were examined for 
MTGCs in the basal decidua, defects in the basal decidua, and 
the presence of myometrial fibres attached to the decidua. 
MTGCs were identified as large trophoblastic cells with 
voluminous cytoplasm and three or more nuclei.614 MTGCs 
were counted only if positively identified as such by both 
observers. All MTGCs present in the full thickness of decidua 
basalis of the placenta were counted in 10 regions of 
standardised length using a graticule in one ocular of the 
microscope. The Merz graticule was projected over the decidua 
basalis of the placenta, and MTGCs were counted at magnifica­
tion x200.
Statistical methods
SPSS 10.0 (SPSS, Chicago, Illinois, USA) for Windows was used 
for statistical analysis. The non-parametric Mann-Whitney U 
test was used to test for differences between RPs and CPs in the 
number of MTGCs per standardised length. Pearson’s x2 test 
was used to test observed differences in frequencies between 
groups. Significance was defined as p<0.05 for all tests.
RESULTS
All RPs were clinically diagnosed as PA. Histologically, 22 of 23 
cases (96%) were PA. In one case (4%) the basal decidua was not 
intact, implying that histologically it should be considered 
placenta accreta.
The obstetric history showed that 5 of 11 (45%) of parous 
women with RP had previously experienced RP, compared with
0 of 6 (0%) women in the CP group (p<0.05, see table 1). For 
the other variables there were no significant differences between 
the two groups, notably not with respect to previous caesarean 
or curettage.
The histological data are shown in table 2. MTGCs were 
present in the basal decidua of 19 of 23 (83%) RPs and in all CPs. 
Quantitatively, the median number of MTGCs per standardised
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Table 2 The number of multinucleated trophoblastic giant cells, defects 
in basal decidua and myometrial fibre attachment in control placentas 
and retained placentas
Control p lace n ta  Retained placenta
(n =  10) (n =  23) p Va lue
MTGCs (number per length 
of deciduas), median 
(range)
1.11 (0.94-3 .75) 0.23 (0-1 .26) < 0 .0 0 1 *
Basal decidua defects, n 
(%)
M yom etria l fibre  
attachment
0 (0 ) 1 (4) NS
Present in any o f the  
slides, n (%)
0 (0) 18 (78) < 0 .0 0 1 *
Present in percentage of 
slides, % (range)
NA 48 (25-100) NA
*M a n n -W h itn e y  U test (two-tailed). 
NA, not applicable; NS, not significant.
length of decidua basalis was significantly lower for RPs (0.23) 
compared with CPs (1.11). Figure 1 shows an example of 
MTGCs in the decidua basalis.
The basal decidua was intact in virtually all RPs (96%) and 
CPs (100%), whereas myometrial fibre attachment to the basal 
decidua was common in RPs (78%) in contrast to CPs (0%). Fig 2 
depicts an example of RP w ith myometrial fibres attached to 
the intact decidua basalis.
DISCUSSION
As to the cause of abnormal placental adhesion in PA, defects in 
the basal decidua are unlikely to be a cause because they were 
absent in 96% of our cases. It is also unlikely that insufficient 
uterine contractions were the primary cause of retainment as in 
all our patients active management of the third stage of labour 
included the use of uterotonics.17 Our study suggests that 
abnormally strong attachment is the more likely mechanism by 
which placentas are abnormally adhesive, as myometrial fibres 
were found attached to the otherwise intact basal decidua in 
78% of RPs in contrast to 0% of CPs. The latter is in line with 
previous studies showing that myometrial attachment is an 
abnormal finding w ith an incidence in randomly examined,
Figure 1 Multinucleated trophoblastic giant cells (MTGCs) in the 
decidua basalis (H&E, x200). At the light microscopic level, MTGCs are 
large cells (compared with the adjacent trophoblastic cells) containing 
two or more nuclei enclosed in a voluminous cytoplasm.14 F, fibrinoid 
layer; V, villi; T, trophoblast cell.
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Figure 2 Myometrial fibres attached to the intact decidua basalis in a 
retained placenta (H&E, x100). V, villi; BD, basal decidua;
M, myometrium fibres.
normally expelled, term placentas of 0.2%19 to 0.9%.20 Myometrial 
attachment in term placentas, as in our study group, must be 
regarded as a diagnostic sign of abnormal adherence.
Myometrial attachment was absent in 22% of our cases of PA. 
Although one might argue that abnormal adhesion did not exist 
in these cases, it seems more likely that it reflects that abnormal 
myometrial attachment in placenta adhesiva is a focal problem, 
as well as the fact that our way of sampling (four samples of 
each placenta) was unable to detect the focal problems in all 
placentas studied. Histochemical staining with, for example, 
aSMj (an anti-smooth muscle antibody), could have increased 
the absolute numbers of myometrium-positive slides, because 
small myometrial fibres are more easily detected in smooth- 
muscle staining.
Defects in the basal decidua were present in 4% of our cases of 
RP. Although defects in the basal decidua are a focal problem, it 
seems unlikely that this was caused by our sampling technique, 
as two previous studies using comparable sampling technique 
reported focally absent decidua in 100% of cases of placenta 
accreta.8 9 We feel that our one case of RP w ith a defect in the 
basal decidua, and which was clinically diagnosed as PA, should 
be histologically classified as placenta accreta.
Frank and Kaufmann hypothesised that fusion of tropho­
blastic cells into MTGCs limits their invasiveness.15 Our finding 
of a significantly reduced presence of MTCGs in the basal 
decidua of abnormally adhesive placentas compared with
controls seems to support this hypothesis. However, it does 
not answer the basic question of whether PA is caused by 
defective fusion of trophoblast cells into MTGCs in the decidua.
Our study does not provide information on the presence of 
MTGCs in the deeper layers of the uterus, as we did not take 
placental bed biopsies. Three previous studies have focused on 
these deeper layers. One study reported the expected presence of 
only a few MTGCs in the decidua and myometrium of 
hysterectomy specimens of placenta creta,9 while the two other 
studies found no significant difference in the number of MTGCs 
in the myometrium of hysterectomy specimens between 
placenta creta and controls.613 We conclude that although we 
did not study the MTGCs in the placenta bed and myometrium, 
in the literature there are no suggestions that fusion of 
trophoblastic cells in MTGCs takes place in deeper layers of 
the myometrium in PA compared w ith CPs.
The cause of defective fusion of trophoblast cells into MTGCs 
is unknown. Theoretically, the fusion could be impaired by 
dysregulation through decidua-derived factors. Uterine natural 
killer cells in the maternal basal decidua have the ability to 
secrete several cytokines, chemokines and angiogenesis-regulat- 
ing molecules that regulate trophoblast inhibition and prolifera- 
tion.21-23 It is conceivable that these factors play a role. More 
research is needed to disclose the role of deciduas-derived factors 
in RP. Recent studies have suggested that in placenta accreta 
defective fusion of trophoblast cells into MTGCs is associated 
w ith excessive numbers of mononuclear trophoblast cells.13 24 
We intend to address these issues in further studies of PA.
In conclusion, RP caused by PA is associated with a reduced 
number of MTGCs in the basal decidua and not by defects in 
the basal decidua. We speculate that these findings may indicate 
that defective fusion of trophoblastic cells into MTGCs plays a 
causative role in PA.
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PAN CREATIC PATHOLOGY M EETING
Wednesday 2nd December 2009 
St Jam es's University Hospital, Leeds
This one-day meeting will focus on the reporting of pancreatic 
cancer specimens (including a live specimen dissection session) 
in the light of the revised RCPath Minimum Dataset that will be 
issued later this year. Further topics included in the programme 
are endocrine pancreatic tumours and their differentials, 
pancreatobiliary cytology, and discussion of training and research 
in pancreatic pathology in the UK. The meeting concludes with an 
Open Forum session, in which difficult cases will be discussed in 
a multidisciplinary approach. 5 CPD credits have been awarded. 
Target audience: specialist pancreatic pathologists, consultants 
with an interest in pancreatic pathology, senior trainees in 
pathology and oncology, members of the pancreatic MDTeam. 
The meeting precedes the Annual Scientific Conference of the 
Pancreatic Society of GB & Ireland, 3-4. December 2009, 
Weetwood Hall, Leeds. The conference programme is multi­
disciplinary and an impressive faculty of national and international 
speakers will address clinical, pathology, training and research 
issues in pancreatic cancer.
To book and for further details, please contact the organizer, Dr C 
Verbeke (Caroline.Verbeke@leedsth.nhs.uk, tel. 0113 2067802) 
or visit www.pancsoc.org.uk.
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